Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585

被引:82
作者
Hickey, GJ
Drisko, J
Faidley, T
Chang, C
Anderson, LL
Nicolich, S
McGuire, L
Rickes, E
Krupa, D
Feeney, W
Friscino, B
Cunningham, P
Frazier, E
Chen, H
Laroque, P
Smith, RG
机构
[1] MERCK SHARP & DOHME RES LABS,DEPT BIOMETR RES,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME RES LABS,DEPT LAB ANIM RESOURCES,RAHWAY,NJ 07065
[3] MERCK SHARP & DOHME RES LABS,DEPT SAFETY ASSESSMENT,RAHWAY,NJ 07065
[4] IOWA STATE UNIV SCI & TECHNOL,DEPT ANIM SCI,AMES,IA 50011
关键词
D O I
10.1677/joe.0.1480371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the effect of hypophyseal transection (HST) on GH secretagogue activity of the non-peptidyl GH secretagogue L-692,585 in the conscious pig, male castrated swine were randomly assigned to either a hypophyseal stalk transection group (HST; n = 3) or to a sham-operated control group (SOC; n = 3). Treatments administered were L-692,585 (100 mu g/kg), human GH-releasing factor(1-29)NH, (GRF; 20 mu g/kg) or L-692,585 (100 mu g/kg) + GRF (20 mu g/kg) on days - 7 to - 3 before surgery and days + 3 to + 8 after surgery. To evaluate the integrity of the pituitary gland, the animals were challenged with corticotropin-releasing hormone (CRH; 150 mu g) or GnRH (150 ng/kg) both before and after surgery. Blood was collected from - 60 to + 180 min post treatment and assayed for GH, cortisol and LH. Before surgery, no significant difference (P > 0.05) in peak GH response (ng/ml) was present between the two groups (SOC vs HST) in response to L-692,585 (101 +/- 12 vs 71 +/- 9) or L-692,585 + GRF (171 +/- 21 vs 174 +/- 21). Only two out of three SOC vs three out of three HST pigs responded to GRF (13 +/- 2 vs 25 +/- 3) resulting in a significant difference between groups. Following surgery, significant differences were present in peak GH response (ng/ml) between SOC and HST groups following L-692,585 (79 +/- 6 vs 13.8 +/- 1.0); however, the response to L-692,55 + GRF was similar (115 +/- 8 vs 94 +/- 7). All animals responded to GRF; however, a significant difference was present between groups due to the magnitude of the responses. Whereas the cortisol responses (ng/ml) to L-692,585 in the SOC and HST groups were similar before surgery, a significant difference was present after surgery (44.4 +/- 6.4 vs 14.6 +/- 2.1). No significant difference was noted between the HST and SOC groups in response to CRH or GnRH either before or after surgery. These results indicated that L-692,585 induced an immediate GH response in the intact animal in contrast to GRF where the GH release was variable. L-692,585 also stimulated an immediate increase in cortisol levels. Transection of the hypophyseal stalk dramatically decreased but did not ablate the GH or cortisol response to L-692,585. Go-administration of L-692,585 + GRF induced an immediate GH response of similar magnitude in the intact and HST animal. We conclude that L-692,585 has a direct but limited action at the level of the pituitary and that an intact hypophyseal stalk is required for a maximal GH and cortisol response. L-692,585 acts with GRF at the level of the pituitary to induce a maximal GH response. These findings suggest that L-692,585 stimulates GH secretion by acting in combination with GRF and interrupting the inhibitory tone of somatostatin on the somatotroph.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 29 条
[1]   GROWTH-HORMONE RESPONSE INDUCED BY SYNTHETIC HUMAN GROWTH HORMONE-RELEASING FACTOR (1-44) IN HEALTHY DOGS [J].
ABRIBAT, T ;
REGNIER, A ;
MORRE, M .
JOURNAL OF VETERINARY MEDICINE SERIES A-ZENTRALBLATT FUR VETERINARMEDIZIN REIHE A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 1989, 36 (05) :367-373
[2]   OVARIAN FUNCTION IN PIGS FOLLOWING HYPOPHYSIAL STALK TRANSECTION OR HYPOPHYSECTOMY [J].
ANDERSON, LL ;
DYCK, GW ;
MORI, H ;
HENRICKS, DM ;
MELAMPY, RM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1967, 212 (05) :1188-&
[3]  
ANDERSON LL, 1991, P SOC EXP BIOL MED, V196, P194, DOI 10.3181/00379727-196-43179
[4]   DESENSITIZATION STUDIES USING PERIFUSED RAT PITUITARY-CELLS SHOW THAT GROWTH HORMONE-RELEASING HORMONE AND HIS-D-TRP-ALA-TRP-D-PHE-LYS-NH2 STIMULATE GROWTH-HORMONE RELEASE THROUGH DISTINCT RECEPTOR-SITES [J].
BLAKE, AD ;
SMITH, RG .
JOURNAL OF ENDOCRINOLOGY, 1991, 129 (01) :11-19
[5]   ON THE ACTIONS OF THE GROWTH HORMONE-RELEASING HEXAPEPTIDE, GHRP [J].
BOWERS, CY ;
SARTOR, AO ;
REYNOLDS, GA ;
BADGER, TM .
ENDOCRINOLOGY, 1991, 128 (04) :2027-2035
[6]   GROWTH-HORMONE (GH)-RELEASING PEPTIDE STIMULATES GH RELEASE IN NORMAL MEN AND ACTS SYNERGISTICALLY WITH GH-RELEASING HORMONE [J].
BOWERS, CY ;
REYNOLDS, GA ;
DURHAM, D ;
BARRERA, CM ;
PEZZOLI, SS ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :975-982
[7]   ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE [J].
BOWERS, CY ;
MOMANY, FA ;
REYNOLDS, GA ;
HONG, A .
ENDOCRINOLOGY, 1984, 114 (05) :1537-1545
[8]  
CHAUNG LY, 1993, 75TH ANN M END SOC L
[9]   A NOVEL NON-PEPTIDYL GROWTH-HORMONE SECRETAGOGUE [J].
CHENG, K ;
CHAN, WWS ;
BUTLER, B ;
WEI, L ;
SMITH, RG .
HORMONE RESEARCH, 1993, 40 (1-3) :109-115
[10]  
CHENG K, 1989, ENDOCRINOLOGY, V124, P2791